2Hayden WR. Sepsis terminology in pediatrics. J Pediatrics, 1994,124(4) :657.
3Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guideline for the use of innovative the rapies in sepsis.The ACCP/SCCM consensus conference committee. American College of chest Physicians/Society of Critical Care Medicine. Chest,1992,101:1644.
4Balk RA, Cerra FB, Dellinger RP. American College of Chest Physicans-Critical Care Medicine Consens Conference: Definitins for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Critical Care Medicine, 1992,20:864.
5Xavier Sae Z-Liorens and Gerge H, Craeken MC Jr. Sepsis syndrome and septic shock in pediatrics:Current concepts of terminology, pathophysiology and management. J Pediatrics, 1993, 123 (4):497.
6Jaye DL, Waites KB. Clinical applications of C-reactive protein in pediatrics. Pediatr Inferct Dis J, 1997,16: 735 - 747.
7McCowen KC, Friel C, Sternberg J, et al. Hypocaloric total parenteral nutrition: effectiveness in prevention of hyperglycemia and infectious complications. A randomized, clin ical trail [J]. Crit Care Med, 2000, 28:3606-3611
8McCowen KC, Abel ED. The contribution of defects in insulin signaling in skeletal muscle to insulin resistance and type 2 diabetes: cellular and molecular aspects. In:Malhotra SK ed. Advances in structural biology [M]. Stamford, CT: Jai Press, 2000.41-64
9Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes [J]. J Clin Endocrinol Metab, 2002, 87(3):978-982
10Stuart CA, Shangraw RE, Prince MJ, et al. Bed-restinduced insulin resistance occurs primarily in muscle [J].Metabolism, 1988, 37:802-806
